April 2022 ARS Meeting
Return to CIRM Meetings and Events
MEETING NOTICE AND AGENDA
REGULAR MEETING OF
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
Date: April 19, 2022
Time: 9:00 am to 11:00 am
Location: 685 Gateway Blvd., Conf. Rm. B
South San Francisco, CA 94080
Due to the expiration of Executive Order N-1-22, which extended the suspension of certain provisions of the Bagley-Keene Open Meeting Act until March 31, 2022 in response to the COVID-19 pandemic, this meeting of the Application Review Subcommittee will be conducted in person and via noticed teleconference locations, which will be made accessible to the public. Members of the public may attend this meeting in person at the address printed above, at a teleconference location listed below, or remotely via the options listed below.
Teleconference Locations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public Comment Instructions
Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:
- Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
- Once we call your name you will have 3 Minutes to make your public comment; please remember to be respectful of the time limit.
- Written comment may be sent to the following email address: kmccormack@cirm.ca.gov.
- Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location.
YouTube: www.youtube.com/cirmtv
Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 857 4194 0861
Passcode: 220419
Open Session
- Call to Order
- Roll Call
Action Items
- Consideration of applications submitted in response to Translational Projects Program Announcement (TRAN 1,2,3 or 4)
- Presentation
- Summaries – Updated 4/11/22
- Consideration of applications submitted in response to Clinical Trial Stage Projects Program Announcement (CLIN 1,2 or 3).
Closed Session
- Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items 3 and 4 above. (Health & Safety Code 125290.30(f) (3) (B) and (C)).
Discussion Items
- Public comment
- Adjournment
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
**NOTICE**
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 510-340-9111.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.
Last Modified: September 16, 2022